Dcf Advisers, LLC Obs Eva Sa Transaction History

Dcf Advisers, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$2.47 - $3.34 $65,455 - $88,510	-26,500 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$2.01 - $5.05 $47,234 - $118,675	-23,500 Reduced 47.0%	26,500 $86,000
Q3 2020 Nov 13, 2020	BUY	$2.46 - $6.15 $123,000 - $307,500	50,000 New	50,000 $124,000

88K

Ticker OBSV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,499,200
Description
ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...

Get notified when there are updates to the investment portfolio of Dcf Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Dcf Advisers, LLC with notifications on news.